Fulvestrant (ICI 182780) CAS 129453-61-8 API Factory High Quality

Description:

Nomen: Fulvestrant (ICI 182780)

CAS: 129453-61-8

Aspectus: Alba ad Off-White Crystalline pulveris

Intenta: 97.0%~ 102.0% (ex sicca basis)

Fulvestrum adhibetur in curatione carcinomatis hormonum-sensitivo antecedens in feminis postmenopausalibus.

API High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple cum High puritate et stabulo Quality
Nomen: Fulvestrant
CAS: 129453-61-8
Fulvestrum adhibetur in curatione carcinomatis hormonum-sensitivo antecedens in feminis postmenopausalibus.
API High Quality, Commercial Production

Chemical Properties:

Nomen chemicum	Fulvestrant
Synonyma	(7α, 17β)-7-[9-[(4,4,5,5,5-Pentafluorpentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3,17-diol;ICI 182780
CAS Number	129453-61-8
CATTUS Number	RF-API81
Stock Status	In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae	C32H47F5O3S
M. Pondus	606.77
Liquescens punctum	104.0~106.0℃
Solubilitas	Solutum in Methanol, Ethanol;Insolubilis in aqua
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Alba ad Off-White Crystalline pulveris
Lepidium sativum	Per IR, HPLC
Imprimis Rotatione Optica	+18.0° to +115.0°
Damnum in Siccatio	≤0.50%
Residere in Ignition	≤0.10%
6-Keto-Fulvestrant	≤0.10%
6,7-Fulvestrant	≤0.10%
Fulvestrant Sulfone	≤0.20%
Fulvestrant Fundo	≤0.30%
Fulvestrant Sterol Dimmer	≤0.80%
Quodlibet individuum non specificatum immunditiam	≤0.10%
Totalis immunditias	≤1.0%
Fulvestrant A	42.0%~ 48.0%
Fulvestrant B	52.0%~58.0%
DMF	≤620ppm
Metalla gravis	≤10ppm
Assay	97.0%~ 102.0% (ex sicca basis)
Repono	Serva in bene clausis levibus renitentibus continentia copia refrigerated in 2~ 8℃
Test Standard	Pharmacopoeia Civitatum Foederatarum (USP) Standard
Consuetudinem	Estrogen Receptor Antagonista

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Fulvestrant (ICI-182780) CAS 129453-61-8, est medicamentum musculi iniectio a comitatu AstraZeneca evoluta et adhibetur in curatione cancri pectoris hormono-sensitivae in feminis postmenopausalibus.Fulvestrum unicum medicamentum antiestrogenium est, quod late amet utendum est post curationem tamoxifen infelicis.Hoc medicamentum endocrinae therapiae genus est, ideo non causat aliquos effectus adversos in chemotherapy vulgo conspicuus, ei relativum bonum praebens obsequium patientis.Multae probationes clinicae inventae sunt 250mg Fulvestrant efficax et constanter tutum sicut secunda linea curationis ad cancer carcinomata provectus.Fulvestrant syntheticum Estrogen Receptor (ER) Antagonista cum IC50 0,94 nM in cella liberorum primordium.Fulvestrum etiam autophagiam et apoptosin inducit et actionem antitumorem habet.